Publication: 2768

Publication: 2768

Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): Update of the SOFT trial

DOI

URL

URL

Google Scholar

Citation:: Ann Oncol vol 28 (9) 2225-2232

Meeting Instance:: SABCS 2017
Year:: 2017
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 2920

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:: U10CA180821

Corr. Author:
Authors:: Gini F Fleming Prudence A Francis István Láng Eva M Ciruelos Meritxell Bellet Hervé R Bonnefoi Miguel A Climent Lorenzo Pavesi Harold J Burstein Silvana Martino Nancy E Davidson Charles E Geyer Jr Barbara A Walley Robert E Coleman Pierre Kerbrat Stefan Buchholz James N Ingle Manuela Rabaglio-Poretti Marco Colleoni Meredith M Regan

Networks:: LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-PA015, OH070

Study: IBCSG-24-02 (SOFT-TEXT)
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: GnRH-agonist, adjuvant therapy, hormone receptor-positive, ovarian function suppression, premenopausal, triptorelin